International Journal of
Reproductive Biomedicine
Tue, May 14, 2024
[Archive]
Volume 11, Issue 11 (12-2013)
IJRM 2013, 11(11): 939-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Amer M, Metawae B, Hosny H, Raef A. Beneficial effect of adding pentoxifylline to processed semen samples on ICSI outcome in infertile males with mild and moderate asthenozoospermia: a randomized controlled prospective crossover study. IJRM 2013; 11 (11) :939-0
URL: http://ijrm.ir/article-1-358-en.html
URL: http://ijrm.ir/article-1-358-en.html
1- Department of Andrology and STDs, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
2- Department of Andrology and STDs, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt , andrology_omen@yahoo.com
2- Department of Andrology and STDs, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt , andrology_omen@yahoo.com
Abstract: (2233 Views)
Background: No extensive studies were done that included the use of pentoxifylline or verify its effect on the outcome of ICSI in cases of mild and moderate asthenozoospermia.
Objective: The aim of this study was to evaluate the effect of pentoxifylline used in preparation of semen samples which doesn't need motility enhancement prior to ICSI.
Materials and Methods: The study was carried on 30 infertile patients where pentoxifylline was used for semen processing (group I), another 30 patients without pentoxifylline (group II) in addition to 60 infertile patients where crossing over of the semen sample was done further subdividing it into 2 subgroups in which the first half of the semen sample was incubated with pentoxifylline (group IIIA) and the second half of the sample without pentoxifylline (group IIIB).
Results: The numbers of oocytes injected, numbers of oocytes fertilized, fertilization rate, the total numbers of embryos, numbers of good embryos and the numbers of embryos transferred of group IIIA were found significantly higher than that of Group IIIB (p=0.00). The overall 6 month pregnancy rate of group I was significantly higher than that of group II (73.3% vs. 60% respectively, p=0.04). The abortion rate of (Group I) and that of (Group II) was found non – significantly different (20% vs. 27.8% respectively, p=0.53).
Conclusion: Pentoxifylline can be used as a useful compound for improving ICSI outcome in semen samples preparation prior to oocytes injection regardless of the state of sperm motility or the degree of asthenozoospermia.
Objective: The aim of this study was to evaluate the effect of pentoxifylline used in preparation of semen samples which doesn't need motility enhancement prior to ICSI.
Materials and Methods: The study was carried on 30 infertile patients where pentoxifylline was used for semen processing (group I), another 30 patients without pentoxifylline (group II) in addition to 60 infertile patients where crossing over of the semen sample was done further subdividing it into 2 subgroups in which the first half of the semen sample was incubated with pentoxifylline (group IIIA) and the second half of the sample without pentoxifylline (group IIIB).
Results: The numbers of oocytes injected, numbers of oocytes fertilized, fertilization rate, the total numbers of embryos, numbers of good embryos and the numbers of embryos transferred of group IIIA were found significantly higher than that of Group IIIB (p=0.00). The overall 6 month pregnancy rate of group I was significantly higher than that of group II (73.3% vs. 60% respectively, p=0.04). The abortion rate of (Group I) and that of (Group II) was found non – significantly different (20% vs. 27.8% respectively, p=0.53).
Conclusion: Pentoxifylline can be used as a useful compound for improving ICSI outcome in semen samples preparation prior to oocytes injection regardless of the state of sperm motility or the degree of asthenozoospermia.
Type of Study: Original Article |
References
1. Tash JS, Means AR. Cyclic adenosine 3'5' monophosphate, calcium and protein posphorylation in flagellar motility. Biol Reprod 1983; 28: 75-104. [DOI:10.1095/biolreprod28.1.75]
2. Flesch FM, Colenbrander B, Van Golde LMG, Gadella BM. Capacitation induces tyrosine phosphorylation of proteins in the boar sperm plasma membranes. Biochem Biophys Res Commun 1999; 262: 787-792. [DOI:10.1006/bbrc.1999.1300]
3. Mitchell LM. Laboratory techniques: Sperm preparation for assisted conception. In: Peter R. Brinsden. Textbook of in vitro fertilization and assisted reproduction the Bourn Hall guide to clinical and laboratory practice. 3rd Ed. CRC Press; 2005: 309-318. [DOI:10.1201/b14680-18]
4. Tesarik J, Mendoza C, Carreras A. Effects of phosphodiesterase inhibitors caffeine and pentoxifylline on spontaneous and stimulus-induced acrosome reaction in human sperm. Fertil Steril 1992; 58: 1185-1189. [DOI:10.1016/S0015-0282(16)55567-8]
5. Rizk B, Fountain S, Avery S, Palmer C, Blayney M, Macnamee M, et al. Successful use of pentoxifylline in male-factor infertility and previous failure of in vitro fertilization: a prospective randomized study. J Assist Reprod Genet 1995; 12: 710-714. [DOI:10.1007/BF02212898]
6. Imoedemhe DA, Sigue AB, Pacpaco EL, Olazo AB. The effect of caffeine on the ability of spermatozoa to fertilize mature human oocytes. J Assist Reprod Genet 1992; 9: 155-160. [DOI:10.1007/BF01203756]
7. Sohn JO, Shin JS, Jeong CJ, Cho YS, Oum KB, Choi DH, et al. Effect of pentoxifylline on the ICSI program udergone in severe asthenozoospermia. Korean J Fertil Steril 2002; 29: 97-103.
8. Takeda N, Abe A, Akimoto S, Kudo T, Machiya R, Onuma M, et al. Clinical outcome of sorting and recovery of ultrasmall amounts of live sperm stimulated with pentoxifylline followed by intracytoplasmic sperm injection. J Mammalian Ova Res 2009; 26: 79-85. [DOI:10.1274/jmor.26.79]
9. World Health Organization, Department of Reproductive Health and Research. WHO laboratory manual for the examination and processing of human semen. 5th Ed. Cambridge, Cambridge University Press; 2010.
10. Palermo GD, Cohen J, Alikani M, Adler A, Rosenwaks Z. Intracytoplasmic sperm injection: a novel treatment for all forms of male factor infertility. Fertil Steril 1995; 63: 1231-1240. [DOI:10.1016/S0015-0282(16)57603-1]
11. Ola B, Afnan M, Sharif K, Papaioannou S, Hammadieh N, Barratt CLR. Should ICSI be the treatment of choice for all cases of in-vitro conception? Hum Reprod 2001; 16: 2485-2490. [DOI:10.1093/humrep/16.12.2485]
12. Al-Hasani S, Küpker W, Baschat AA, Sturm R, Bauer O, Diedrich C, et al. Mini-swim-up: a new technique of sperm preparation for intracytoplasmic sperm injection. J Assist Reprod Genet 1995; 12: 428-433. [DOI:10.1007/BF02211143]
13. Quinn P. The development and impact of culture media for assisted reproductive technologies. Fertil Steril 2004; 81: 27-29. [DOI:10.1016/j.fertnstert.2003.10.003]
14. Tesarik J, Greco E. The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod 1999; 14: 1318-1323. [DOI:10.1093/humrep/14.5.1318]
15. Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod 2000; 15: 2634-2643. [DOI:10.1093/humrep/15.12.2634]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
